Geezer Butler recently hailed the advantages of artificial intelligence, saying it helped him develop songs for his upcoming solo album. The bassist said his former bandmate and Sabbath guitarist Tony ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

I would like to add the most famous problem of the interviews and different coding platforms as it comes as the daily challenge on platforms and we can only perform the merge sort on the linked list ...

Just this past school year, I attended a meeting with my department administrator, reviewing teacher observation data. The numbers didn’t lie—but they didn’t tell the full story. Despite our best ...

DEAR MISS MANNERS: A car wash I patronize has two single-occupant washrooms, one labeled “Men,” the other “Ladies.” I had availed myself of the men’s room, and as I was closing the door, someone ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...